SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-358698
Filing Date
2021-12-16
Accepted
2021-12-16 09:14:58
Documents
12
Period of Report
2021-12-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d170193d8k.htm   iXBRL 8-K 25009
  Complete submission text file 0001193125-21-358698.txt   147823

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20211216.xsd EX-101.SCH 2895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20211216_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20211216_pre.xml EX-101.PRE 11407
5 EXTRACTED XBRL INSTANCE DOCUMENT d170193d8k_htm.xml XML 3374
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 211496142
SIC: 8090 Services-Misc Health & Allied Services, NEC